SA Asks: Which Large Pharmas are prone to announce huge M&A offers?

Final 12 months round this time, a number of main drugmakers introduced vital M&A offers to assist fill their pipelines, together with Bristol-Myers Squibb’s (BMY) proposed takeovers of Karuna and RayzeBio, and AbbVie’s (ABBV) offers to purchase ImmunoGen and Cerevel.

Which brings us to